Toxic Shock Syndrome Screening
Cross-source consensus on Toxic Shock Syndrome Screening from 1 sources and 5 claims.
1 sources · 5 claims
Preparation
Risks & contraindications
Other
Other
Highlighted claims
- Candidates are screened before enrolment for the tst gene encoding toxic shock syndrome toxin-1. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Only candidates who are tst-negative are enrolled in the trial. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Candidates who test positive for tst are excluded and verbally notified by study medical staff. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- A second swab for TSS-related bacterial screening is analyzed only if TSS symptoms occur during that cycle. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Tampon and menstrual cup use are described as carrying residual TSS risk when retained longer than recommended. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland